Turmoil in the FDA: A high-ranking official quits after the Plan B delay
“I can no longer serve as staff when scientific and clinical evidence, fully evaluated and recommended for approval by the professional staff here, has been overruled . . . The recent decision announced by the Commissioner about emergency contraception, which continues to limit women’s access to a product that would reduce unintended pregnancies and reduce abortions, is contrary to my core commitment to improving and advancing women’s health.”